This podcast episode examines the fate of the Bristol amoxicillin plant, detailing its history, decline, and the heroic efforts of Rick Jackson to revitalize it as US Antibiotics, emphasizing the critical issues surrounding the sustainability of American drug manufacturing and the impacts of global competition on national health security.
